search
Osaka
Trends
- 1Kobayashi Pharmaceutical may be target of ¥500 billion buyout●Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat
Kobayashi Pharmaceutical, the Japanese company at the center of a supplement contamination scandal involving suspected deaths, is reportedly considering a potential buyout offer valued at more than ¥500 billion. The news puts the embattled Osaka-based drugmaker back in the spotlight, with attention on who might take over the firm and what it would mean for the company's future after the scandal damaged its reputation and finances.
- 2Godzilla Expo on minus world coming to Tokyo and Osaka●製作資料やVFXメイキングなどからゴジラの軌跡を紐解く「ゴジラ博 マイナスの世界」東京と大阪で11月に開催 – @DIME アットダイム 製作資料やVFXメイキングなどからゴジラの軌跡を紐解く「ゴジラ博 マイナスの世界」東京と大阪で11月に
A Godzilla exhibition titled 'Godzilla Expo: The World of Minus' will be held in Tokyo and Osaka in November, tracing the franchise's history through production materials and VFX making-of content. The event ties into renewed interest around the latest Godzilla film, with midnight premiere screenings also drawing attention among fans in Japan.